Nothing Special   »   [go: up one dir, main page]

KR101212346B1 - Cosmetic compositions for preventing and curing acne - Google Patents

Cosmetic compositions for preventing and curing acne Download PDF

Info

Publication number
KR101212346B1
KR101212346B1 KR1020050049364A KR20050049364A KR101212346B1 KR 101212346 B1 KR101212346 B1 KR 101212346B1 KR 1020050049364 A KR1020050049364 A KR 1020050049364A KR 20050049364 A KR20050049364 A KR 20050049364A KR 101212346 B1 KR101212346 B1 KR 101212346B1
Authority
KR
South Korea
Prior art keywords
acne
extract
skin
preventing
inflammatory
Prior art date
Application number
KR1020050049364A
Other languages
Korean (ko)
Other versions
KR20060128153A (en
Inventor
백지훈
김관철
류근석
Original Assignee
애경산업(주)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 애경산업(주) filed Critical 애경산업(주)
Priority to KR1020050049364A priority Critical patent/KR101212346B1/en
Publication of KR20060128153A publication Critical patent/KR20060128153A/en
Application granted granted Critical
Publication of KR101212346B1 publication Critical patent/KR101212346B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/234Cnidium (snowparsley)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/42Cucurbitaceae (Cucumber family)
    • A61K36/424Gynostemma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

본 발명은 여드름 예방 및 치료에 효과가 있고 안전성이 우수한 화장료 조성물에 관한 것으로서, 좀 더 상세하게는 5-리폭시게나제 활성을 억제하여 항염증효과가 있으며 피부에 안전하고 여드름 치료에 우수한 천궁 및 돌외 추출물을 함유하는 화장료 조성물에 관한 것이다. 본 발명의 화장료 조성물은 천궁(Cnidium officinale Makino)과 돌외(Gynostemma pentaphyllum (Thunberg) Makino)를 물 또는 유기용매를 각각 또는 혼합한 것을 용매로 하여 추출한 추출물을 통상적인 화장료에 일정 비율로 첨가 혼합하여 얻음을 특징으로 한다.The present invention relates to a cosmetic composition that is effective in preventing and treating acne and having excellent safety, and more particularly, inhibits 5-lipoxygenase activity and thus has an anti-inflammatory effect and is safe for skin and excellent in treating acne. It relates to a cosmetic composition containing an extract. The cosmetic composition of the present invention is obtained by adding and mixing an extract extracted with Cnidium officinale Makino and Gynostemma pentaphyllum (Thunberg) Makino as a solvent or a mixture of water or an organic solvent at a predetermined ratio to a conventional cosmetic It is characterized by.

Description

여드름 치료 및 예방용 화장료 조성물{Cosmetic compositions for preventing and curing acne}Cosmetic compositions for treating and preventing acne

본 발명은 여드름 예방 및 치료에 효과가 있고 안전성이 우수한 화장료 조성물에 관한 것으로서, 보다 상세하게는 5-리폭시게나제 활성을 억제하여 항염증효과가 있으며 피부에 안전하며 여드름 예방 및 치료 효과가 우수한 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition that is effective in preventing and treating acne and having excellent safety, and more particularly, to inhibit 5-lipoxygenase activity, which has an anti-inflammatory effect, is safe for skin, and has an excellent acne prevention and treatment effect. It relates to a composition.

여드름이란 주로 사춘기 남녀에서 발생하며 면포, 구진, 농포, 낭종 또는 결절 형성을 특징으로 하는 모낭피지선의 만성 염증성 질환을 일컫는다. 여드름은 주로 사춘기에 발생하여 20대 중반에 쇠퇴하지만 성인에서도 발생한다. 남자보다 여자가 여드름 발생시기가 더 빠르지만 남자에서 더 심한 형태로 나타난다. 여드름을 발생시키는 요인으로는 유전적 요인과 환경적 요인을 배제한다면 네 가지 정도가 있다고 보고되고 있다. 첫 째는 피지선에서의 과도한 피지 분비에 의한 여드름 발생이다. 피지의 형성은 남성호르몬인 테스토스테론이 5알파-리덕타제 효소에 의해 디하이드로 테스토스테론으로 전환되면서 시작된다. 즉 남성호르몬의 비정상적인 증가 또는 이와 관련된 여러 기전을 통하여 피지선의 기능이 항진되고 그 결과 과 잉의 피지를 생성하게 된다. 둘 째는 모낭 과각화에 의한 면포형성이다. 생성된 피지는 피부밖으로 원할하게 배출되어야 하지만 모낭의 과각화로 인하여 모공이 막혀 피지의 원할한 배출이 억제되고 그 결과 모낭내에 피지가 정체되어 미세면포를 형성하게 된다. 면포는 폐쇄성 면포와 개방성 면포로 구분된다. 폐쇄성 면포란 피지선 밖으로 분비되지 못한 피지가 피부 표면 아래에 뭉쳐 있는 상태로 좁쌀처럼 오돌토돌하게 돌출되어 있는 것이 특징이며 흰색을 띄고 있다. 개방성 면포는 정체된 면포가 덩어리형태로 모공을 막고 끝이 산화되어 검은색으로 변하여 흔히 점처럼 보이는 여드름을 말한다. 세 번째는 여드름 균(Propionibacterium acnes)의 과다증식에 의한 여드름 발생이다. 여드름 균은 피부 상재균으로써 피지선 내에 존재하나 피지분비가 증가함으로써 여드름균도 증식하여 피지성분인 트리글리세라이드(triglyceride)를 자유지방산(free fatty acid)으로 전환시켜 여드름 발생을 자극하게 된다. 넷 째는 염증반응에 의한 여드름 형성이다. 여드름 균에 의해 생성되는 염증 유발 물질들에 의해 염증반응을 일으키면서 붉게 부어오른 구진이나 농을 포함한 농포와 같은 여드름이 발생하게 된다(한국피부장벽학회지, 제4권1호: 62-70. (2000)).Acne is a chronic inflammatory disease of the hair follicle sebaceous gland, which occurs mainly in puberty men and women and is characterized by the formation of cotton, papules, pustules, cysts or nodules. Acne usually occurs in puberty and declines in the mid-20s, but it also occurs in adults. Women develop acne faster than men, but appear more severe in men. It is reported that there are four kinds of factors that cause acne, excluding genetic and environmental factors. The first is the development of acne due to excessive sebum secretion in the sebaceous glands. Sebum formation begins when testosterone, a male hormone, is converted to dihydrotestosterone by a 5-alpha-reductase enzyme. In other words, the abnormal increase in male hormone or related mechanisms promotes sebaceous gland function, resulting in excess sebum. Second is scleroderma by hair follicle hyperkeratosis. The generated sebum should be discharged smoothly out of the skin, but due to the hyperkeratosis of the hair follicles, the pores are blocked and the smooth discharge of sebum is suppressed. Cotton cloth is divided into closed and open cotton cloth. The obstructive scrim is characterized by protruding sebum that is not secreted out of the sebaceous glands and sticking out like a millet. Open scalp refers to acne that looks like dots, with stagnant scalp clogging the pores in the form of lumps and oxidizing the tip to black. The third is the development of acne by overproliferation of acne bacteria (Propionibacterium acnes). Acne bacteria are present in the sebaceous glands as skin flora, but by increasing sebum secretion, acne bacteria also multiply, and triglyceride, a sebum component, is converted into free fatty acid to stimulate acne. Fourth is the formation of acne by inflammatory reactions. Inflammatory substances produced by acne bacteria cause inflammatory reactions such as red swollen papules and pustules, including pus (Korean Society for Skin Barriers, Vol. 4, No. 1: 62-70. 2000)).

세포로막으로부터 아라키돈산(arachidonic acid)의 유리와 대사작용은 몇 가지 다른 경로에 의해 전-염증성(pro-inflammatory) 대사산물을 생산한다. 여기에는 두 개의 중요한 경로가 있으며 5-리폭시게나제(5-lipoxygenase: 5-LOX) 및 사이클로옥시게나제(cyclooxygenase: COX)에 의해 매개된다. 이러한 경로들은 각각 염증성 반응의 개시와 진행에 중요한 역할을 하는 루코트리엔과 프로스타글란딘을 생성 하는데 이것들은 염증성 세포의 조직 침윤을 촉진하여 염증반응을 연장시킨다. 특히 5-리폭시게나제(5-LOX)에 의해 생성되는 루코트리엔(leukotrienes)은 습진, 홍반, 건선, 소양증 및 여드름과 같은 피부질환에 관여한다고 알려져 있다(Pharmacology, Mary J. Mycek).The release and metabolism of arachidonic acid from the cell membrane produces pro-inflammatory metabolites by several different pathways. There are two important pathways, mediated by 5-lipoxygenase (5-LOX) and cyclooxygenase (COX). These pathways produce leukotrienes and prostaglandins, each of which play an important role in the initiation and progression of the inflammatory response, which promotes tissue infiltration of inflammatory cells and prolongs the inflammatory response. In particular, leukotrienes produced by 5-lipoxygenase (5-LOX) are known to be involved in skin diseases such as eczema, erythema, psoriasis, pruritus and acne ( Pharmacology , Mary J. Mycek).

여드름을 예방 및 치료하기 위해서는 피지분비 조절, 과각화 억제, 여드름균 과증식 억제, 염증반응 조절 등이 고려되어야 한다. 종래에는 피지분비를 조절하고(대한민국특허 제10-0368126호, 대한민국특허공개 제2001-0097012호), 여드름균인 프로피오니박테리움 아크네에 대한 증식을 억제하는(대한민국특허공개 제2002-0044851호, 제2003-0084484호, 제2003-0082676호) 연구가 보고된 바 있으나 염증반응 메카니즘과 관련하여 연구된 사례는 부족한 편이다.In order to prevent and treat acne, sebum secretion control, hyperkeratosis control, acne bacteria hyperproliferation control, inflammatory response control, etc. should be considered. Conventionally, it regulates sebum secretion (Korean Patent No. 10-0368126, Korean Patent Publication No. 2001-0097012), and inhibits the growth of acne bacteria Propionibacterium acne (Korean Patent Publication No. 2002-0044851, 2003-0084484, 2003-0082676) Although studies have been reported, few studies have been conducted regarding inflammatory response mechanisms.

한편 살리실산이나 비타민 A 유도체인 레티노익산 제제를 사용해서 모공의 각질을 제거하고, 벤조일 퍼옥사이드를 사용함으로써 여드름균의 성장을 억제하는 방법을 사용하고 있으나 살리실산 제제의 치료효과가 미비하고 피부 발적, 부종 또는 피부 기피증 등을 일으킬 수 있으며, 벤조일 퍼옥사이드의 경우 자극이 있고 심하면 가렵고 화끈거리는 부작용이 있다. 염증성 여드름의 치료를 위해 의약품으로 국소도포용 항생제인 클린다마이신, 에리트로마이신, 테트라사이클린, 설폰아마이드 등이 사용되나(피부과학, 대한피부과학회 교과서 편찬위원회) 이들 항생제의 사용은 내성균이 생길 위험이 있고 과민 반응으로 소양감을 동반한 홍반성 구진이 생길 수 있다(대한피부과학회지, 38(1):1-14(2000)). 상기한 바와 같이 종래에는 여드름 치료를 위해 피지분비 억제, 여드름균 증식 억제, 면포 용해 등에 대한 연구 가 대부분이어서 피지선의 만성 염증성 질환인 여드름을 치료하기위한 항염증 연구가 절실히 필요한 실정이다.In the meantime, the salicylic acid and vitamin A derivative retinoic acid preparations are used to remove the dead skin cells and benzoyl peroxide to inhibit the growth of acne bacteria. Or it can cause skin scleroderma, benzoyl peroxide has irritation and severe itching and burning side effects. Topical coating antibiotics such as clindamycin, erythromycin, tetracycline, and sulfonamide are used for the treatment of inflammatory acne (Dermatology, Korean Dermatology Textbook Compilation Committee). The reaction may cause erythematous papules with pruritus (Korean Journal of Dermatology, 38 (1): 1-14 (2000)). As described above, in order to treat acne, most studies on sebaceous gland secretion, acne bacteria growth inhibition, cotton cloth dissolution, and the like, an anti-inflammatory study for treating acne, a chronic inflammatory disease of the sebaceous gland, is urgently needed.

이에 본 발명자들은 이러한 문제점을 고려하여, 여드름의 예방 및 치료 효과가 뛰어나고 장시간 사용해도 피부에 안전성이 우수한 화장품을 개발하고자 연구한 결과, 항염증 효과가 있고 피부에 안전한 돌외 추출물 또는 돌외 추출물과 천궁 추출물을 함유하는 화장료를 완성하였다.In view of these problems, the present inventors have studied to develop cosmetics that are excellent in the prevention and treatment effect of acne and excellent in the safety even for long-term use, and have anti-inflammatory effects and are safe for skin. A cosmetic containing was completed.

상기한 목적을 달성하기 위한 본 발명은 돌외 추출물을 함유하는 여드름 치료 및 예방용 화장료 조성물을 제공한다.The present invention for achieving the above object provides a cosmetic composition for treating and preventing acne containing an extra stone extract.

또한 본 발명은 돌외 추출물과 천궁 추출물을 함유하는 여드름 치료 및 예방용 화장료 조성물을 제공한다.In another aspect, the present invention provides a cosmetic composition for treating and preventing acne containing a dodol extract and a cheongung extract.

본 발명의 여드름 치료 및 예방용 화장료 조성물은 천궁(Cnidium officinale Makino)과 돌외(Gynostemma pentaphyllum (Thunberg) Makino)를 물 또는 유기용매를 각각 또는 혼합한 것을 용매로 하여 추출한 추출물을 통상적인 화장료에 일정 비율로 첨가 혼합하여 얻음을 특징으로 한다.Cosmetic composition for the treatment and prevention of acne of the present invention is a ratio of the extract extracted with Cnidium officinale Makino and Gynostemma pentaphyllum (Thunberg) Makino as a solvent or a mixture of water or an organic solvent, respectively, in a certain proportion to a conventional cosmetic It is characterized by the addition obtained by mixing.

본 발명의 또 다른 구성에 따르면 상기 유기용매로는 바람직하기로는 아세톤, 에틸아세테이트, 디에틸에테르, 벤젠, 클로로포름, 헥산, 탄소수 1 내지 4의 저급 알코올에서 선택된 하나 또는 그 이상의 것이 일정 비율로 혼합된 것이 사용될 수 있다.According to another configuration of the present invention, the organic solvent is preferably one or more selected from acetone, ethyl acetate, diethyl ether, benzene, chloroform, hexane, lower alcohol having 1 to 4 carbon atoms in a predetermined ratio. May be used.

더욱이 본 발명에 따른 천궁과 돌외 추출물을 함유하는 화장료에 있어, 본 발명의 천궁 및 돌외 추출물이 부가되는 화장료의 제형으로는 유연 화장수(스킨), 로션, 에센스, 크림 등 통상의 화장료 제형에 부가되어 제조될 수 있다.Furthermore, in the cosmetics containing the cheongoung and doldol extract according to the present invention, the formulation of the cosmetic product to which the cheongoung and doldol extract of the present invention is added is added to conventional cosmetic formulations such as flexible lotion (skin), lotion, essence, cream, etc. Can be prepared.

본 발명은 천궁과 돌외 추출물을 화장료의 건조중량에 대하여 각각 혹은 혼합하여 0.001~10중량%의 함량으로 함유하여 여드름 예방 및 치료효과를 가진 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition having the effect of preventing and treating acne by containing the amounts of 0.001 to 10% by weight, respectively, or mixed with the cheongung and doldol extract based on the dry weight of the cosmetic.

본 발명에 사용된 천궁(Cnidium officinale Makino)은 산형목 산형과 갯사상자속에 해당하는 것으로서 우리 나라 각처의 밭에서 흔히 재배하는 다년초이다. 키는 30-60cm이고 잎은 호생, 2회 깃꼴겹잎이다. 꽃은 흰색이고 겹산형화서는 크고, 작은 산형화서는 15개 정도, 총포와 작은 총포는 각각 5-6개 있다. 열매를 맺지 않은 식물이다(한국식물도감, 이영노). 천궁에 대해서는 민감성 피부용 화장료의 조성물 성분으로 보고된 바 있고, 항궤양 치료제와 피부미백용 화장료 조성물로 알려져 있다. Cnidium officinale Makino used in the present invention is a perennial herb that is commonly cultivated in fields in various parts of our country as it corresponds to the mountainous tree type and the mud. The height is 30-60cm and the leaves are regenerated, two-times. The flowers are white and the double acidic flowers are large, about 15 small mountain flowers, and 5-6 small guns and small guns. It is a plant without fruit (Korean Plant Book, Lee Young-no). As for the uterus, it has been reported as a composition component of a cosmetic for sensitive skin, and is known as an antiulcer therapeutic agent and a cosmetic composition for skin whitening.

돌외(Gynostemma pentaphyllum (Thunberg) Makino)는 쌍떡잎식물 박목 박과의 여러해살이 덩굴식물로서 우리나라 남부와 경상북도, 울릉도 섬의 숲 가장자리에 분포한다. 마디에 흰 털이 있고, 줄기에 덩굴손이 있으며 잎은 호생, 손바닥 모양의 겹잎, 작은 잎은 3-7장, 막질, 좁은 난상 타원형, 좁은 난형, 끝이 뾰족하고, 양 면에 다세포성 흰 털이 있다가 없어지며, 길이 4-8cm, 폭 2-3cm, 가장자리에 톱니가 있다. 꽃은 양성화, 황록색, 잎겨드랑이에서 원추화서 또는 총상 원추화서로 달리고, 길이는 8-15cm이다. 꽃받침 갈래는 극히 소형이고 화관은 5갈래이며 갈래 의 길이는 3mm, 피침형, 끝이 뾰족하다. 열매는 박과, 둥근모양이며 지름이 6-8mm, 검은 녹색으로 익고 상반부에 1개의 가로선이 있다(한국식물도감, 이영노). 돌외에 관해서는 건강음료차의 제조법(특1019840003341, 특1019840007337), 항산화 효과(Zhong Yao Cai. 1999 Jun;22(6):303-6, Nitric Oxide. 2003 Jun;8(4):235-42), 돌외에서 분리한 성분에 관한 연구(J Nat Prod. 1995 Apr;58(4):512-9, J Nat Prod. 1996 Dec;59(12):1143-5, Eur J Pharm Sci. 1999 Jul;8(3):187-91)가 알려져 있다.Dol-Eup ( Gynostemma pentaphyllum (Thunberg) Makino) is a perennial vine plant of the dicotyledonous gourd, which is distributed at the edge of forests in southern Korea, Gyeongsangbuk-do, and Ulleungdo Island. Node with white hairs, tendrils on stems, leaves regenerated, palm-shaped double leaves, small leaves 3-7, membranous, narrow egg-shaped oval, narrow ovate, pointed end, multicellular white hairs on both sides It disappears, 4-8cm long, 2-3cm wide, with teeth on the edges. Flowers run from bisexual, yellow-green, axillary to conical or gunshot inflorescences, 8-15 cm long. Calyx branch is extremely small, corolla is 5 branch, branch length is 3mm, lanceolate, pointed end. Fruits are gourd, round, 6-8mm in diameter, black green, with one horizontal line in the upper half (Korean Plant Book, Lee Young-no). Regarding Dol et al, the preparation method of health drink tea (JP 1019840003341, EP 1019840007337), antioxidant effect (Zhong Yao Cai. 1999 Jun; 22 (6): 303-6, Nitric Oxide. 2003 Jun; 8 (4): 235-42 ), Studies on the Components Isolated from Stones (J Nat Prod. 1995 Apr; 58 (4): 512-9, J Nat Prod. 1996 Dec; 59 (12): 1143-5, Eur J Pharm Sci. 1999 Jul. ; 8 (3): 187-91).

이하 본 발명을 하기 실험예를 통하여 보다 자세하게 설명한다. 그러나 이들 실험예는 본 발명에 대한 이해를 돕기위한 것일뿐 본 발명의 범위가 하기 실시예 및 실험예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to the following experimental examples. However, these experimental examples are only for the purpose of understanding the present invention, and the scope of the present invention is not limited to the following examples and experimental examples.

실험예 1. 5-리폭시게나제 활성억제 실험Experimental Example 1. 5-lipoxygenase activity inhibition experiment

15ml 튜브에 리놀렌산(linolenic acid) 1ml와 시료 0.1ml, 리폭시게나제(lipoxygenase) 0.9ml를 혼합기로 일정하게 섞어주었다. 25℃에서 10분간 인큐베이션 한 후 20% 트리클로로아세트산 0.5 ml와 0.6% 티오바르비투산(Thiobarbituric acid) 1ml를 첨가한다. 끓는 물에 20분 동안 끓인 후 얼음물에 3분간 냉침하였다. n-부탄올 2ml를 튜브에 넣어 20초 동안 혼합기로 섞어주고 원심분리기로 3500rpm에서 5분간 원심분리하였다. 상층액을 535nm에서 흡광도를 측정하여 리폭시게나제 저해율(%)을 나타내었다. 저해율은 하기의 식에 따라 구하였다.In a 15 ml tube, 1 ml of linolenic acid, 0.1 ml of sample, and 0.9 ml of lipoxygenase were constantly mixed with a mixer. After incubation at 25 ° C. for 10 minutes, 0.5 ml of 20% trichloroacetic acid and 1 ml of 0.6% Thiobarbituric acid are added. It boiled in boiling water for 20 minutes and then cooled in ice water for 3 minutes. 2 ml of n-butanol was added to the tube, mixed with a mixer for 20 seconds, and centrifuged at 3500 rpm for 5 minutes. The supernatant was measured for absorbance at 535 nm, indicating a percent inhibition of lipoxygenase. Inhibition rate was calculated according to the following equation.

Figure 112005030546311-pat00001
Figure 112005030546311-pat00001

양성대조군으로 노르디하이드로구아이아레트산(Nordihydroguaiaretic acid: NDGA)를 사용하였고, 돌외는 전초를 에탄올로 추출한 후 용매를 감압 농축하여 휘발시켜 만든 분말상의 제제를 인산완충생리식염수(PBS)에 실험농도로 희석하여 사용하였다. 상기 실험예를 따라 처리하여 하기 표 1과 같은 결과를 얻었다.Nodihydroguaiaretic acid (NDGA) was used as a positive control, and dolga was extracted with ethanol, and then a powdered product prepared by volatilizing the solvent under reduced pressure was tested in phosphate buffered saline (PBS). Diluted to concentration and used. Treatment was performed according to the experimental example to obtain a result as shown in Table 1.

5-리폭시게나제 활성억제 효과5-lipoxygenase activity inhibitory effect 농도(%)density(%) 억제율(%)
% Inhibition
NDGANDGA 천궁 추출물Celestial extract 돌외 추출물Dolan extract 0.010.01 47.547.5 38.638.6 29.829.8 0.10.1 8686 81.281.2 66.466.4 1One 9494 82.782.7 72.172.1

표 1에서 알 수 있는 바와 같이, 천궁 추출물은 0.1% 농도에서 대조군인 NDGA와 상응한 효과를 보였으며 돌외 추출물은 농도 의존적으로 5-리폭시게나제 활성을 억제함으로써 유효한 효과를 나타내었다.As can be seen in Table 1, the extract of the uterus showed a corresponding effect with the control NDGA at 0.1% concentration, and the extradol extract showed an effective effect by inhibiting 5-lipoxygenase activity in a concentration-dependent manner.

실험예 2. 마우스 귀를 이용한 항염증 실험Experimental Example 2. Anti-inflammatory experiment using mouse ears

돌외 추출물 및 천궁 추출물에 대한 항염증 효과를 알아보기 위하여 마우스 좌측귀를 대조부위, 우측귀를 시험부위로 하고 시료를 적용하기 전에 에탄올로 귀를 깨끗하게 세척한 후 시료 20㎕를 1일 1회 4일간 지속적으로 도포하였다. 마지막 도포 1시간 후에 좌측귀에는 에탄올을 우측귀에는 아라키돈산(Arachidonic acid) 2mg을 도포하여 1시간 후 귀의 부종정도를 마이크로미터로 측정하였다. 항염효과는 아라키돈산 처리군을 기준으로 부종억제 정도로 판정하였으며 그 결과를 표 2에 나타내었다. 억제율은 다음 계산식에 따라 구하였다.In order to examine the anti-inflammatory effects on dodol extracts and uterine extracts, the mouse left ear was used as the control site and the right ear as the test site, and the ear was washed thoroughly with ethanol before applying the sample. The application was continued for a day. One hour after the last application, ethanol was applied to the left ear and 2 mg of arachidonic acid was applied to the right ear. Anti-inflammatory effect was determined as the degree of edema inhibition based on the arachidonic acid treatment group and the results are shown in Table 2. Inhibition rate was calculated according to the following formula.

Figure 112005030546311-pat00002
Figure 112005030546311-pat00002

A : 대조군 귀의 평균두께 (아라키돈산 처리 후 부종 발생한 두께)A: Average thickness of control ears (thickness of edema after arachidonic acid treatment)

B : 시험군 귀의 평균두께 (시료처리 후 부종 발생한 두께)B: average thickness of test group ears (thickness of edema after sample treatment)

돌외 추출물 및 천궁 추출물의 항염증 효과Anti-Inflammatory Effects of Dodol Extract and Cervix Extracts 시료sample 농도(%)density(%) 용매menstruum 억제율(%)% Inhibition 스테아릴 글리레티네이트(Stearyl Glycyrretinate)Stearyl Glycyrretinate 0.10.1 에탄올ethanol 4.54.5 천궁 추출물Celestial extract 0.10.1 에탄올ethanol 7.87.8 천궁 추출물Celestial extract 0.010.01 에탄올ethanol 4.34.3 돌외 추출물Dolan extract 0.10.1 에탄올ethanol 6.36.3 돌외 추출물Dolan extract 0.010.01 에탄올ethanol 5.15.1 천궁, 돌외 추출물 혼합시료(1:1)Cheonggung and Dool Extract Mixed Samples (1: 1) 0.10.1 에탄올ethanol 9.79.7 천궁, 돌외 추출물 혼합시료(1:1)Cheonggung and Dool Extract Mixed Samples (1: 1) 0.010.01 에탄올ethanol 6.56.5

위의 결과에서 알 수 있듯이, 천궁은 0.1%에서 7.8%의 억제율을 보였고 돌외는 0.1% 농도에서 6.3%의 억제율을 나타내었다. 항염효과가 좋다고 알려져 있는 스테아릴 글리레티네이트의 0.1%에서의 억제율 4.5%보다 효과가 더 높게 나타났다. 특히 천궁 추출물과 돌외 추출물을 동일양으로 혼합한 시료의 경우 0.1%에서 9.7%의 염증억제율을 보임으로써 추출물 각각의 효과보다 더욱 탁월한 항염증 효과가 있음을 알 수 있었다.As can be seen from the above results, the archery showed an inhibition rate of 0.1% to 7.8%, and the dodol showed an inhibition rate of 6.3% at 0.1% concentration. The effect was higher than the inhibition rate of 4.5% at 0.1% of stearyl glycretinate, which is known to have good anti-inflammatory effect. In particular, the sample containing the same amount of cheongung extract and dodol extract showed an inhibitory rate of inflammation from 0.1% to 9.7%.

실험예 3. 여드름 치료 상용성 시험Experimental Example 3. Acne Treatment Compatibility Test

통상의 로션 및 스킨 제형에 천궁추출물과 돌외추출물을 동일양으로 제조한 시료 0.1%를 첨가하여 만든 화장료로 여드름 치료효과와 피부 자극여부를 알아보고자 하였다. 피험자는 16세에서 18세 사이의 여자로서 얼굴에 염증성 여드름인 구진이 다수인 학생들로 구성하였다. 한 군당 15명씩으로 구성하였고 평가시 블라인드 테스트(blind test)를 실시하였다. 피험자는 돌외 추출물이 0.1% 함유된 스킨, 로션 화장품을 1일 아침, 저녁으로 2회 사용하였으며 2개월간 적용 후 피험자 설문에 의한 주관평가와 시험자에 의한 육안 평가로 측정하였다. The purpose of this study was to investigate the effect of acne treatment and skin irritation with cosmetics made by adding 0.1% of the samples prepared in the same amount to the common lotion and skin formulations. The subjects were women between the ages of 16 and 18 years old and consisted of students with multiple papules, inflammatory acne on the face. Each group consisted of 15 people and a blind test was performed during the evaluation. Subjects used skin and lotion cosmetics containing 0.1% extra stone extract twice a day, morning and evening, and after two months of application, subjects evaluated by subject questionnaire and visual evaluation by tester.

표 3은 여드름 치료효과를 5 포인트 스케일로 나타내었고, 표 4는 평가시 화장료의 피부에 대한 자극성 여부를 설문을 통해 확인한 결과이다. Table 3 shows the acne treatment effect on a five point scale, Table 4 shows the results of confirming whether the irritation to the skin of the cosmetics during the evaluation through a questionnaire.

여드름 치료효과Acne Treatment 로션Lotion 스킨skin

피험자 주관 평가


Subject Subjective Assessment
55 22 1One
44 1111 1111 33 33 22 22 -- 1One 1One -- -- 평균Average 4.24.2 3.83.8

시험자 육안 평가


Visual assessment of the examiner
55 1One 1One
44 1010 1212 33 44 1One 22 -- 1One 1One -- -- 평균Average 3.83.8 3.863.86

* 5 포인트 스케일* 5 point scale

5: 매우 좋아짐, 4: 좋아짐, 3: 잘 모르겠음, 2: 나빠짐, 1: 매우 나빠짐.5: very good, 4: better, 3: not sure, 2: worse, 1: very bad.

피부 자극성Skin irritation 자극성pepper 인원수(명)Number of people 로션Lotion 스킨skin 있다have -- -- 없다none 1515 1515

표 3에서 보는 바와 같이, 천궁과 돌외 혼합추출물 0.1%를 함유한 로션과 스킨은 각각 피험자 주관평가에서는 4.2, 3.8이었고 시험자 육안 평가에서는 3.8, 3.86으로 여드름 치료에 효과가 있는 것으로 나타났다.As shown in Table 3, the lotions and skins containing 0.1% of the uterus and extra stone mixture extracts were 4.2 and 3.8 in the subject's subjective evaluation and 3.8 and 3.86 in the subject's visual evaluation, respectively.

또한 표 4에서 보는 바와 같이, 여드름을 가진 피험자가 2개월간 천궁과 돌외 혼합추출물이 함유된 로션과 스킨을 사용한 결과 피부에 대한 자극이 없어 안전하다는 것을 알 수 있다.In addition, as shown in Table 4, as a result of using a lotion and skin containing acne mixed extracts and cheongung for two months subjects with acne, it can be seen that there is no irritation to the skin is safe.

상기 본 발명의 구성에 따른 천궁과 돌외 추출물은 5-리폭시게나제 활성 억제 및 동물실험에서의 항염증 효과가 있으며 더욱이 이들 추출물이 혼합되었을 때 효능 상승작용이 있어 여드름을 예방 및 치료하는데 효과적일 뿐 아니라, 피부에 대한 안전성도 우수하다.The cheongung and dodol extracts according to the composition of the present invention have 5-lipoxygenase activity inhibition and anti-inflammatory effects in animal experiments, and furthermore, they are effective in preventing and treating acne when these extracts are mixed. In addition, the skin is also safe.

Claims (4)

돌외 추출물 및 천궁 추출물을 함유함을 특징으로 하는 여드름 예방 및 개선용 화장료 조성물.A cosmetic composition for preventing and improving acne, characterized in that it contains a dodol extract and a cheongung extract. 삭제delete 삭제delete 제 1 항에 있어서, 천궁 추출물과 돌외 추출물을 1:1로 혼합하여 조성물의 총 중량에 대하여 0.001 내지 10.0 중량% 함유하는 것을 특징으로 하는 여드름 예방 및 개선용 화장료 조성물.The cosmetic composition for preventing and improving acne according to claim 1, wherein the cheongung extract and the extra stone extract are mixed 1: 1 to contain 0.001 to 10.0 wt% based on the total weight of the composition.
KR1020050049364A 2005-06-09 2005-06-09 Cosmetic compositions for preventing and curing acne KR101212346B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020050049364A KR101212346B1 (en) 2005-06-09 2005-06-09 Cosmetic compositions for preventing and curing acne

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020050049364A KR101212346B1 (en) 2005-06-09 2005-06-09 Cosmetic compositions for preventing and curing acne

Publications (2)

Publication Number Publication Date
KR20060128153A KR20060128153A (en) 2006-12-14
KR101212346B1 true KR101212346B1 (en) 2012-12-13

Family

ID=37730861

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020050049364A KR101212346B1 (en) 2005-06-09 2005-06-09 Cosmetic compositions for preventing and curing acne

Country Status (1)

Country Link
KR (1) KR101212346B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102189376B1 (en) * 2020-02-26 2020-12-11 (주)셀트리온 Composition For Anti-inflammation and Prevention of Hair loss Comprising the Indicator Ingredient isolated from the Extract of Gynostemma Pentaphyllum
KR20210050085A (en) 2019-10-28 2021-05-07 재단법인 제주테크노파크 Pharmaceutical composition comprising mixed extract of Gynostemma phetaphyllum and black radish

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101357024B1 (en) 2011-01-28 2014-02-04 환인제약 주식회사 A composition comprising mixed herbal extract of Cnidii Rhizoma and Polygoni cuspidati Radix for treating or preventing respiratory disease
KR102411893B1 (en) * 2020-05-29 2022-06-23 바이오스펙트럼 주식회사 Composition for inhibiting sebum secretion comprising Chestnut bur extract as an active ingredient
KR102435006B1 (en) * 2020-11-20 2022-08-24 주식회사 바이오에프디엔씨 External Composition Comprising the Plant Cell Culture of Gynostemma pentaphyllum for Improving Skin

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030124205A1 (en) 2001-12-28 2003-07-03 Avon Products, Inc. Topical cosmetic composition having a natural plant active ingredient and method of using same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030124205A1 (en) 2001-12-28 2003-07-03 Avon Products, Inc. Topical cosmetic composition having a natural plant active ingredient and method of using same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210050085A (en) 2019-10-28 2021-05-07 재단법인 제주테크노파크 Pharmaceutical composition comprising mixed extract of Gynostemma phetaphyllum and black radish
KR102189376B1 (en) * 2020-02-26 2020-12-11 (주)셀트리온 Composition For Anti-inflammation and Prevention of Hair loss Comprising the Indicator Ingredient isolated from the Extract of Gynostemma Pentaphyllum

Also Published As

Publication number Publication date
KR20060128153A (en) 2006-12-14

Similar Documents

Publication Publication Date Title
Pundir et al. Ethnomedicinal uses, phytochemistry and dermatological effects of Hippophae rhamnoides L.: A review
JPH03190809A (en) Skin external preparation
US10758475B2 (en) Sun block formulation
CA3055669A1 (en) Skin treatment methods
KR101212346B1 (en) Cosmetic compositions for preventing and curing acne
CN109248105A (en) A kind of makeup removing stick and preparation method thereof
JP2007269743A (en) Skin care preparation
Sahu et al. Formulation and development of whitening polyherbal face cream
FR3061434B1 (en) COSMETIC COMPOSITION COMPRISING AN ASSOCIATION OF PONGAMIA OIL AND PENTYLENE GLYCOL 4-T-BUTYLCYCLOHEXANOL FOR CONTROLLING ROSACEA
CN104095783A (en) Traditional Chinese medicine antiphlogistic and acne-removing beauty cream and preparation method thereof
KR20170133560A (en) A cosmetic composition for scalp and hair improvement comprising multiple extract of combined medicinal herbs
KR100754748B1 (en) Compositiion for Inhibiting 5?-Reductase Activity and Cosmetic Composition for Inhibiting Secretion of Sebum containing Extract of Ulmus davidiana as Active Ingredient
JP2005350412A (en) Nerve growth factor production inhibitor, and skin care preparation for external use, cosmetic, quasi-medicine, itching-preventing and treating agent, and atopic dermatitis medicine which contain the nerve growth factor production inhibitor
KR102272771B1 (en) Cosmetic composition for alleviating sebum secretion comprising Carthamus tinctorius extract or mixture extract of Carthamus tinctorius and Areca catechu
KR101252560B1 (en) Cosmetic composition containing extracts of Impatiens balsamina L. for controlling anti-acne or anti-comedone
KR100702329B1 (en) Compositiion for Inhibiting 5?-Reductase Activity and Cosmetic Composition for Inhibiting Secretion of Sebum containing Extract of Chelidonium majus as Active Ingredient
KR102162904B1 (en) Hair coloring composition and the manufacturing process having antimicrobial and antiflammatory and deodorizing activity and ammonia odor removal effet
JP2007314462A (en) External preparation
CN113081933A (en) Acne-removing composition and preparation method and application thereof
JPH0393710A (en) External preparation or cosmetic for skin or hair containing rearing inhibitor of propionibacterium acnes
KR102499533B1 (en) Anti-inflammatory cosmetics material, Revitalizing cosmetics containing the same and Manufacturing method thereof
KR20040056079A (en) Cosmetic composition for preventing and therapeutic for a pimple
KR100540463B1 (en) Composition containing portulaca oleracea L. extract for anti-inflammation and anti-irritation
KR101692910B1 (en) Composition for relieving seborrheic dermatitis and method for manufacturing thereof
KR19990053760A (en) Pack composition for prevention and treatment of acne

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20151202

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20161206

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20171204

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20181205

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20191204

Year of fee payment: 8